Sponsor Pipeline

Mirador Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07113522 A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease Inflammatory Bowel Disease (IBD) Recruiting
Phase 1
NCT07219368 A First-in-Human Single and Multiple Ascending Dose Study of MT-201 Healthy Volunteer Recruiting
NCT07423299 A First-in-Human Single and Multiple Ascending Dose Study of MT-251 Healthy Volunteers Recruiting
Disease Areas
Crohn's Disease (1) Ulcerative Colitis (1)
Get alerts when Mirador Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free